Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 10Completed 8Active not recruiting 7Withdrawn 4Recruiting 4Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

Lenalidomide 2Cyclophosphamide 2ibrutinib 1fludarabine 1Vincristine 1Ropivacaine 1Rituximab 1R-CHOP protocol 1Prednisone 1Nivolumab 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Maintenance 1Magnetic Resonance Spectroscopy 1Leukapheresis 1JNJ-64619178 1JNJ-64264681 1Inosine Monophosphate 1Fluorodeoxyglucose F18 1Etoposide 1Educational Status 1Doxorubicin 1Decitabine 1Brentuximab Vedotin 1Blood Specimen Collection 1Biopsy, Fine-Needle 1Bendamustine Hydrochloride 1Angptl4 protein, mouse 17-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × R-CHOP protocol × Lymphoid × Clear all
NCT07348575 2026-01-16

A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma

Second Affiliated Hospital of Nanchang University

Phase 3 Enrolling by invitation
80 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡